About AQEMIA
AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline.
Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.
Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data.
We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimization.
As a Medicinal Chemist you will work at the interface of chemistry and biology, designing and optimizing compounds that drive our projects from hit generation through to preclinical candidates. If you’re excited to leverage your scientific expertise to help build the future of therapeutics, we’d love to hear from you!
Why Join Us ?
At AQEMIA, we work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast-growing company and team.
Expanding Drug Discovery Pipeline : Focused on critical diseases like immuno-oncology, with in vivo proof of concept/patent stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.
Interdisciplinary Team : brilliant talent from tech and life sciences.
Experienced Leadership : Founders with 15+ years at ENS, Oxford, Cambridge, and BCG.
DeepTech Recognition: Part of French Tech 120 and France 2030.
Prime Location : Based in central Paris with the possibility of 2 remote days per week.
International Environment : English-speaking team with relocation support and French lessons if needed.
Strong Financial Backing : $60M raised from leading European deeptech investors